Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Marta Agostinho"'
Autor:
Ana Sofia Morais, Maria Mendes, Marta Agostinho Cordeiro, João J. Sousa, Alberto Canelas Pais, Silvia M. Mihăilă, Carla Vitorino
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 615 (2024)
This review outlines the evolutionary journey from traditional two-dimensional (2D) cell culture to the revolutionary field of organ-on-a-chip technology. Organ-on-a-chip technology integrates microfluidic systems to mimic the complex physiological e
Externí odkaz:
https://doaj.org/article/406811a8a245458d97e8c65a23ba30eb
Publikováno v:
Pharmaceutics, Vol 16, Iss 3, p 321 (2024)
By definition, biosimilar medicinal products are biological medicinal products that are similar to other biological medicinal products that are already on the market—the reference medicinal products. Access to biosimilar medicines is a current real
Externí odkaz:
https://doaj.org/article/d76631678d5849d7bea1a6fb12b1b66f
Autor:
Cordeiro, Marta Agostinho1 (AUTHOR) martaisabel99@gmail.com, Vitorino, Carla1,2 (AUTHOR) csvitorino@ff.uc.pt, Sinogas, Carlos3 (AUTHOR) sinogas@sapo.pt, Sousa, João J.1,2 (AUTHOR) csvitorino@ff.uc.pt
Publikováno v:
Pharmaceutics. Mar2024, Vol. 16 Issue 3, p321. 23p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marta Agostinho, Pedro Casaleiro
Publikováno v:
Midas: Museus e Estudos Interdisciplinares, Vol 5
Externí odkaz:
https://doaj.org/article/2d5d937c532b4bf8b12cce18a9293f2e
Autor:
Morais, Ana Sofia, Mendes, Maria, Cordeiro, Marta Agostinho, Sousa, João J., Pais, Alberto Canelas, Mihăilă, Silvia M., Vitorino, Carla
Publikováno v:
Pharmaceutics; May2024, Vol. 16 Issue 5, p615, 20p
Autor:
João Ferreira, Ronald T. Hay, Ellis Jaffray, José Rino, Inês Pinheiro, Joana Cardoso, Rafael Costa, Fernando Ferreira, Vera Santos, Marta Agostinho
Type 2 topoisomerases, in particular the α isoform in human cells, play a key role in cohesion and sister chromatid separation during mitosis. These enzymes are thus vital for cycling cells and are obvious targets in cancer chemotherapy. Evidence ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcab1efe70b422fe935943f78d98b59e
https://doi.org/10.1158/0008-5472.c.6497592
https://doi.org/10.1158/0008-5472.c.6497592
Autor:
João Ferreira, Ronald T. Hay, Ellis Jaffray, José Rino, Inês Pinheiro, Joana Cardoso, Rafael Costa, Fernando Ferreira, Vera Santos, Marta Agostinho
Supplementary Figure 1 from Conjugation of Human Topoisomerase 2α with Small Ubiquitin-like Modifiers 2/3 in Response to Topoisomerase Inhibitors: Cell Cycle Stage and Chromosome Domain Specificity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2018392bcef34187f7c2325b5133435c
https://doi.org/10.1158/0008-5472.22374813
https://doi.org/10.1158/0008-5472.22374813
Autor:
João Ferreira, Ronald T. Hay, Ellis Jaffray, José Rino, Inês Pinheiro, Joana Cardoso, Rafael Costa, Fernando Ferreira, Vera Santos, Marta Agostinho
Supplementary Figure 1 Legend from Conjugation of Human Topoisomerase 2α with Small Ubiquitin-like Modifiers 2/3 in Response to Topoisomerase Inhibitors: Cell Cycle Stage and Chromosome Domain Specificity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bab2a4939213c094927a832dc2eda7c
https://doi.org/10.1158/0008-5472.22374816
https://doi.org/10.1158/0008-5472.22374816
Publikováno v:
EMBO reports. 23